Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL1251

GANIRELIX
💊 Approved Drug
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
💊 Approved Drug
CC/N=C(\NCC)NCCCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CCCCN/C(=N/CC)NCC)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@@H](Cc1cccnc1)NC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(C)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O

Basic Information

ChEMBL ID CHEMBL1251
Name GANIRELIX
Phase Approved
Structure Type BOTH
InChI Key GJNXBNATEDXMAK-PFLSVRRQSA-N
Therapeutic ✓ Yes

Known Names

Ganirelix Orgalutran
0
Targets
0
Activities
0
Assay Types
0
PK Parameters
0
Publications
2
Known Names
4
Indications
1
Mechanisms

Molecular Properties

1570.3
MW (Da)

Drug Information

Molecule Type Protein
First Approval 1999
Availability Prescription
Chirality Single Enantiomer

Routes of Administration

Parenteral

Flags

Natural Product
USAN Stem -relix
USAN Year 1991

Extended Properties

Molecular Formula C80H113ClN18O13
MW 1570.35

Mechanism of Action

Mechanism Action Type Target Direct Efficacy
Gonadotropin-releasing hormone receptor antagonist ANTAGONIST Gonadotropin-releasing hormone receptor

Indications

Infertility, Female Reproductive Techniques, Assisted Infertility Polycystic Ovary Syndrome

ATC Classification

H01CC01
ganirelix
Level 1: SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
Level 2: PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES

Data from ChEMBL 36 via Core Engine